Scinai Immunotherapeutics Ltd. (SCNI)
NASDAQ: SCNI · Real-Time Price · USD
1.540
-0.900 (-36.89%)
At close: Sep 15, 2026, 4:00 PM EDT
1.440
-0.100 (-6.49%)
Pre-market: Sep 16, 2026, 7:10 AM EDT
Scinai Immunotherapeutics Employees
Scinai Immunotherapeutics had 45 employees as of December 31, 2025. The number of employees increased by 14 or 45.16% compared to the previous year.
Employees
45
Change (1Y)
14
Growth (1Y)
45.16%
Revenue / Employee
$33,044
Profits / Employee
-$57,756
Market Cap
877.83K
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 45 | 14 | 45.16% |
| Dec 31, 2024 | 31 | 0 | - |
| Dec 31, 2023 | 31 | -2 | -6.06% |
| Dec 31, 2022 | 33 | 18 | 120.00% |
| Dec 31, 2021 | 15 | -6 | -28.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Valion Bio | 52 |
| Jaguar Health | 47 |
| Virax Biolabs Group | 26 |
| Silexion Therapeutics | 14 |
| Biodexa Pharmaceuticals | 11 |
| Decoy Therapeutics | 11 |
| Oragenics | 3 |
| Bone Biologics | 2 |
SCNI News
- 7 days ago - Scinai Concludes PC111 Arrangements and Refocuses Capital on NanoAb Platform and Growing CDMO Business - PRNewsWire
- 23 days ago - Scinai Reports First Half 2026 Corporate Highlights and Results with Spotlight on Growing CDMO Momentum - PRNewsWire
- 26 days ago - Scinai Immunotherapeutics Ltd – ADR trading halted, news pending - TheFly
- 5 weeks ago - Scinai Strengthens CDMO Leadership with Appointment of Eran Kuratz as Head of Supply Chain and Business Process Administration - PRNewsWire
- 3 months ago - Scinai Reports First Quarter 2026 Financial Results and Provides Corporate Update Highlighting Expansion of CDMO Platform and Advancement of Strategic Growth Initiatives - PRNewsWire
- 3 months ago - Scinai Biopharma Services Appoints Eilon Elmalem as Site Head of Yavne CDMO Facility - PRNewsWire
- 4 months ago - Scinai Immunotherapeutics to Lead Strategic Roundtable Discussion on Oral Therapies and the Future of Biologics at the 7th Dermatology Drug Development Summit Europe - PRNewsWire
- 4 months ago - Why Is Scinai Immunotherapeutics Stock (SCNI) Up Today? - TipRanks